LITERATURE & NEW TEST RELEASES

Flyers| Newsletter | Recent Publications | Other Literature

Flyers

• Assessing breast cancer markers 2/2008
• Beta catenin (nuclear) - Marker of abdominal fibromatosis & other selected mesenchymal tumors
• Breast Marker Studies
• Contract research services
• CDX2 - Intestine-specific transcription factor
• Dermatopathology Studies
• Effects of Tissue Fixation on ER, PR & HER2 Breast Marker Immunohistochemistry
• EGFR - Evaluation for treatment with Erbitux™
• Esoteric antibodies
• FISH Studies Available
• FISH studies: 1p19q - For detection of loss of 1p36 & 19q13 in oligodendroglioma
• FISH studies: t(9;22) corresponding to the BCR-ABL translocation - For chronic myeloid leukemia 2/2008
• FISH Studies: t(11;14) - For mantle cell lymphoma
• FISH studies: t(11;22) - For PNET/Ewing sarcoma
• FISH Studies: t(14;18) - For follicular lymphoma
• FISH studies: t(15;17) - For acute promyelocytic leukemia 2/2008
• FISH studies: t(X;18) - For synovial sarcoma
• FISH studies: EGFR - For detection of amplification of EGFR, a predictive biomarker
• FISH studies: Lymphomas & Leukemias
• FISH studies: Solid Tumors / Other
• FISH studies: Topoisomerase IIa - For detection of amplification of topoisomerase IIa, a predictive biomarker in breast carcinomas
• Flow Cytometry, nine-color
• HER2 - Leaders in HER-2 Testing in Breast Cancer
• HER2 IHC Validation Services at PhenoPath - Don't Procrastinate: Time To Validate!
• HER2 IHC Validation Service - Questions and Answers
• Identification of Organisms
• Metastatic Carcinoma of Unknown Primary Site
• Molar Pregnancies - p57 and chromosome 17 FISH for evaluation of ploidy studies
• MSI-H - Identifying colorectal adenocarcinomas with mismatch repair enzyme loss
• Oncodiagnostics - Identifying The Targets of Targeted Therapies in Tissue Sections
• PhenoNet - A state-of-the-art, web based, reporting system allowing clients secure, easy and timely access to their reports.
• PAX-2 - For identifying metastatic renal cell carcinoma
• Assessment of B and T cell clonality by PCR
• VEGF - For anti-angiogenesis therapy
• ZAP-70 - Defines a subset of CLL/SLL with poor outcome

Recent Publications

Please see our Staff Page for Recent Publications by PhenoPath physicians and scientists.

Other Literature

• Phenomena: PhenoPath's Quarterly Newsletter

Please contact us to receive the following literature pieces:

• Guide to Clinical Services
• Contract Research Services

Back to top